Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Incorporation of Mutations and Bone Marrow Fibrosis into the Revised International Prognostic Scoring System in Patients with Myelodysplastic Syndromes

Youshan Zhao, ChunKang Chang

Blood (2022) 140 (Supplement 1): 4063–4064.

https://doi.org/10.1182/blood-2022-165202

Published: 2022

Journal Articles

Reduction of Dicer1 By Multiple Myeloma Cells in Mesenchymal Stem Cells Promotes Cellular Senescence and Tumor-Supporting Effect and Decreases the Differentiation

Juan Guo, Xiao Li, MD, Youshan Zhao, Chengming Fei, Chunkang Chang, PhD, Sida Zhao, Qingqing Zheng

Blood (2017) 130 (Supplement 1): 4399.

https://doi.org/10.1182/blood.V130.Suppl_1.4399.4399

Published: 2017

Journal Articles

Dysregulation of ANKRD11 Influenced Hematopoisis By Histone Acetylation-Mediated Gene Expression in Myelodysplastic Syndrome

Youshan Zhao, MD, Feng Xu, Juan Guo, MD, Sida Zhao, MD, Chunkang Chang, MD PhD, Xiao Li, MD PhD

Blood (2016) 128 (22): 4292.

https://doi.org/10.1182/blood.V128.22.4292.4292

Published: 2016

Journal Articles

Labile Plasma Iron (LPI), More Practical and More Sensitive to Iron Overload in Myelodysplastic Syndromes

Chunkang Chang, MDPhD, Shucheng Gu, MD, Juan Guo, MD, Youshan Zhao, MD, Chengming Fei, MD, Xiao Li, MD PhD

Blood (2015) 126 (23): 5230.

https://doi.org/10.1182/blood.V126.23.5230.5230

Published: 2015

Journal Articles

Chidamide, a Novel Histone Deacetylase Inhibitor, Displays Potent Antitumor Activity Against MDS Cells Mainly through JAK2/STAT3 Signaling Inhibition

Chunkang Chang, MDPhD, Sida Zhao, MD, Juan Guo, MD, Youshan Zhao, MD, Chengming Fei, MD, Shucheng Gu, MD, Xiao Li, MD PhD

Blood (2015) 126 (23): 5233.

https://doi.org/10.1182/blood.V126.23.5233.5233

Published: 2015

Journal Articles

Activation of Notch-Hes Signaling Pathway Impairs Osteogenic Differentiation and Hematopoietic Stem Cell-Supporting Capacitiy of Mesenchymal Stromal Cells Derived from Myelodysplastic Syndromes Patients

Chunkang Chang, MDPhD, Chengming Fei, MD, Juan Guo, MD, Youshan Zhao, MD, Shucheng Gu, MD, Xiao Li, MD PhD

Blood (2015) 126 (23): 2857.

https://doi.org/10.1182/blood.V126.23.2857.2857

Published: 2015

Journal Articles

A Primary Study of the Gene Mutations in Predicting Treatment Response to Decitabine in Patients with MDS

Chunkang Chang, MDPhD, Youshan Zhao, MD, Feng Xu, Xiao Li, MD PhD

Blood (2015) 126 (23): 1689.

https://doi.org/10.1182/blood.V126.23.1689.1689

Published: 2015

Journal Articles

Downregulation of Dicer1 Promotes Cellular Senescence and Decreases the Differentiation and Stem Cell-Supporting Capacities of MSCs in Patients with Myelodysplastic Syndrome

Youshan Zhao, Dong Wu, Chengming Fei, Juan Guo, Shucheng Gu, Feng Xu, Zheng Zhang, Chunkang Chang, Xiao Li, MD PhD

Blood (2014) 124 (21): 4365.

https://doi.org/10.1182/blood.V124.21.4365.4365

Published: 2014

Journal Articles

Clinical Observation Of Decitabine Treatment In Selected Patients With Lower Risk Myelodysplastic Syndromes

Chunkang Chang, Zheng Zhang, Youshan Zhao, Xiao Li, MD, PhD

Blood (2013) 122 (21): 5202.

https://doi.org/10.1182/blood.V122.21.5202.5202

Published: 2013

Journal Articles

Protein-Coding and Non-Coding RNA Expression Profiles Of Mesenchymal Stem Cells In Patients With Myelodysplastic Syndromes

Youshan Zhao, Chunkang Chang, Xiao Li, MD, PhD

Blood (2013) 122 (21): 1572.

https://doi.org/10.1182/blood.V122.21.1572.1572

Published: 2013

Journal Articles

Impaired Osteogenic Differentiation Of Mesenchymal Stem Cells Derived From Bone Marrow Of Patients With Low-Risk Myelodysplastic Syndromes

Chunkang Chang, Chengming Fei, Youshan Zhao, Juan Guo, Xiao Li, MD, PhD

Blood (2013) 122 (21): 1579.

https://doi.org/10.1182/blood.V122.21.1579.1579

Published: 2013

Journal Articles

Reduced Response to Stromal Cell-Derived Factor-1(SDF-1) May Lead to Low Expression of p57kip2 in the Bone Marrow of Patients with De Novo Myelodysplastic Syndromes (MDS)

Youshan Zhao, Chunkang Chang, Juan Guo, Shucheng Gu

Blood (2011) 118 (21): 2782.

https://doi.org/10.1182/blood.V118.21.2782.2782

Published: 2011

NARROW

Incorporation of Mutations and Bone Marrow Fibrosis into the Revised International Prognostic Scoring System in Patients with Myelodysplastic Syndromes

Reduction of Dicer1 By Multiple Myeloma Cells in Mesenchymal Stem Cells Promotes Cellular Senescence and Tumor-Supporting Effect and Decreases the Differentiation

Dysregulation of ANKRD11 Influenced Hematopoisis By Histone Acetylation-Mediated Gene Expression in Myelodysplastic Syndrome

Labile Plasma Iron (LPI), More Practical and More Sensitive to Iron Overload in Myelodysplastic Syndromes

Chidamide, a Novel Histone Deacetylase Inhibitor, Displays Potent Antitumor Activity Against MDS Cells Mainly through JAK2/STAT3 Signaling Inhibition

Activation of Notch-Hes Signaling Pathway Impairs Osteogenic Differentiation and Hematopoietic Stem Cell-Supporting Capacitiy of Mesenchymal Stromal Cells Derived from Myelodysplastic Syndromes Patients

A Primary Study of the Gene Mutations in Predicting Treatment Response to Decitabine in Patients with MDS

Downregulation of Dicer1 Promotes Cellular Senescence and Decreases the Differentiation and Stem Cell-Supporting Capacities of MSCs in Patients with Myelodysplastic Syndrome

Clinical Observation Of Decitabine Treatment In Selected Patients With Lower Risk Myelodysplastic Syndromes

Protein-Coding and Non-Coding RNA Expression Profiles Of Mesenchymal Stem Cells In Patients With Myelodysplastic Syndromes

Impaired Osteogenic Differentiation Of Mesenchymal Stem Cells Derived From Bone Marrow Of Patients With Low-Risk Myelodysplastic Syndromes

Reduced Response to Stromal Cell-Derived Factor-1(SDF-1) May Lead to Low Expression of p57kip2 in the Bone Marrow of Patients with De Novo Myelodysplastic Syndromes (MDS)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only